Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by JLGeminion Sep 16, 2010 10:20am
316 Views
Post# 17455335

RE: ReoBlast - Two Clarifications

RE: ReoBlast - Two Clarifications

Haititrader, I do not have the time or desire to rebut your post.  I do want to clarify two points. 

 

1.  Read my post to Boardwalk.  I do not see Oncolytics going on the auction block.  I see the structure morphing into a joint venture.  Some Big Pharma companies, who can use Reolysin in combination with their proprietary drugs, will fund trials to make it happen and manage the distribution.  The market correction to over $1/2 billion market cap will ensure that they pay a fair price.

 

2.  Your knowledge of Canadian politics and Oncolytics is not deep.  Oncolytics is a Calgary based company, the heartland of Prime Minister Harper’s Tory Party and where his riding is located.  The first human trial of Reolysin was in Alberta.  The trial results gave Oncolytics the credibility to attract independent practitioners in the UK and US, and get regulatory approvals.  The Alberta trial paved the way.  Getting Provincial approval for it reflects the political clout of some of their Board members.  The Canada Healthcare system will have room for Reolysin and there will be national pride in its success.  The West will love to have a success story to rival Bantings’ at the University of Toronto in the East!

 

Thank you for your post as another example of the manipulators’ attempts to distract attention away from the market correction rally to a stock price above $7.00.  Should I cast you as M5?

Bullboard Posts